Avita Medical Inc (AVH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avita Medical Inc (AVH) has a cash flow conversion efficiency ratio of 0.411x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.32 Million ≈ $-3.77 Million USD) by net assets (AU$-12.96 Million ≈ $-9.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Avita Medical Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Avita Medical Inc - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Avita Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Avita Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avita Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Calida Holding AG
SW:CALN
|
0.208x |
|
Chaintech Technology Corp
TW:2425
|
0.062x |
|
Eastern Water Resources Development and Management Public Company Limited
F:7ES1
|
0.037x |
|
Torimbia Socimi S.A.
MC:YTRM
|
0.191x |
|
Captor Therapeutics S.A.
WAR:CTX
|
-0.346x |
|
So-Young International Inc
NASDAQ:SY
|
N/A |
|
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS
|
-2.256x |
|
Sunspring Metal Corp
TW:2062
|
0.035x |
Annual Cash Flow Conversion Efficiency for Avita Medical Inc (1994–2025)
The table below shows the annual cash flow conversion efficiency of Avita Medical Inc from 1994 to 2025. For the full company profile with market capitalisation and key ratios, see AVH market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$4.50 Million ≈ $3.18 Million |
AU$-48.94 Million ≈ $-34.63 Million |
-10.878x | -1303.85% |
| 2024-06-30 | AU$49.06 Million ≈ $34.71 Million |
AU$-38.01 Million ≈ $-26.90 Million |
-0.775x | -243.95% |
| 2023-06-30 | AU$124.47 Million ≈ $88.07 Million |
AU$-28.04 Million ≈ $-19.84 Million |
-0.225x | -33.48% |
| 2022-06-30 | AU$147.08 Million ≈ $104.07 Million |
AU$-24.82 Million ≈ $-17.56 Million |
-0.169x | +46.28% |
| 2021-06-30 | AU$72.40 Million ≈ $51.23 Million |
AU$-22.75 Million ≈ $-16.09 Million |
-0.314x | 0.00% |
| 2020-06-30 | AU$104.91 Million ≈ $74.23 Million |
AU$-32.96 Million ≈ $-23.32 Million |
-0.314x | +65.95% |
| 2019-06-30 | AU$20.86 Million ≈ $14.76 Million |
AU$-19.25 Million ≈ $-13.62 Million |
-0.923x | +26.32% |
| 2018-06-30 | AU$13.98 Million ≈ $9.89 Million |
AU$-17.51 Million ≈ $-12.39 Million |
-1.252x | +25.05% |
| 2017-06-30 | AU$5.12 Million ≈ $3.62 Million |
AU$-8.56 Million ≈ $-6.05 Million |
-1.671x | -44.22% |
| 2016-06-30 | AU$6.85 Million ≈ $4.85 Million |
AU$-7.94 Million ≈ $-5.62 Million |
-1.158x | +23.76% |
| 2015-06-30 | AU$4.22 Million ≈ $2.98 Million |
AU$-6.41 Million ≈ $-4.53 Million |
-1.519x | -21.27% |
| 2014-06-30 | AU$5.53 Million ≈ $3.91 Million |
AU$-6.92 Million ≈ $-4.90 Million |
-1.253x | -80.71% |
| 2013-06-30 | AU$10.46 Million ≈ $7.40 Million |
AU$-7.25 Million ≈ $-5.13 Million |
-0.693x | -39.03% |
| 2012-06-30 | AU$8.55 Million ≈ $6.05 Million |
AU$-4.27 Million ≈ $-3.02 Million |
-0.499x | -189.70% |
| 2011-06-30 | AU$16.99 Million ≈ $12.02 Million |
AU$-2.92 Million ≈ $-2.07 Million |
-0.172x | +57.73% |
| 2010-06-30 | AU$3.98 Million ≈ $2.81 Million |
AU$-1.62 Million ≈ $-1.15 Million |
-0.407x | +39.77% |
| 2009-06-30 | AU$6.93 Million ≈ $4.91 Million |
AU$-4.69 Million ≈ $-3.32 Million |
-0.676x | -137.36% |
| 2008-06-30 | AU$12.96 Million ≈ $9.17 Million |
AU$-3.69 Million ≈ $-2.61 Million |
-0.285x | +65.16% |
| 2007-06-30 | AU$10.98 Million ≈ $7.77 Million |
AU$-8.97 Million ≈ $-6.35 Million |
-0.818x | +7.29% |
| 2006-06-30 | AU$11.15 Million ≈ $7.89 Million |
AU$-9.83 Million ≈ $-6.96 Million |
-0.882x | -26.70% |
| 2004-06-30 | AU$8.66 Million ≈ $6.13 Million |
AU$-6.03 Million ≈ $-4.26 Million |
-0.696x | -202.25% |
| 2003-06-30 | AU$8.25 Million ≈ $5.83 Million |
AU$-1.90 Million ≈ $-1.34 Million |
-0.230x | -80.03% |
| 2002-06-30 | AU$4.53 Million ≈ $3.21 Million |
AU$-579.75K ≈ $-410.21K |
-0.128x | +15.36% |
| 2001-06-30 | AU$5.38 Million ≈ $3.81 Million |
AU$-813.24K ≈ $-575.42K |
-0.151x | +38.59% |
| 1999-06-30 | AU$1.10 Million ≈ $781.22K |
AU$-271.66K ≈ $-192.22K |
-0.246x | -79.20% |
| 1997-06-30 | AU$4.98 Million ≈ $3.52 Million |
AU$-683.59K ≈ $-483.68K |
-0.137x | -15.69% |
| 1996-06-30 | AU$4.48 Million ≈ $3.17 Million |
AU$-532.00K ≈ $-376.42K |
-0.119x | +8.92% |
| 1995-06-30 | AU$5.82 Million ≈ $4.12 Million |
AU$-758.00K ≈ $-536.33K |
-0.130x | -1841.18% |
| 1994-06-30 | AU$6.55 Million ≈ $4.63 Million |
AU$49.00K ≈ $34.67K |
0.007x | -- |
About Avita Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more